The Editors in Chief has retracted this article because of irregularities in Fig. 4 A and G. In Fig. 4 A the BGC823 and NC/BGC823 panels for 0 h appear to overlap and the BGC823 and NC/BGC823 panels for 24 h appear to overlap. In Fig. 4G the BGC823 and NC/BGC823 panels appear to overlap and the SGC7901 and NC/SGC7901 panels appear to overlap. The study had also not received sufficient ethics approval. None of the authors agree to this retraction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found athttps://doi.org/10.1186/s12935-020-01285-w.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Sun, D., Wang, Y., Wang, H. et al. Retraction Note: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2. Cancer Cell Int 22, 321 (2022). https://doi.org/10.1186/s12935-022-02744-2
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-022-02744-2